Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. - Wikidata - awgldk - TriplyDB

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.

http://www.wikidata.org/entity/Q31028998

about

Prime-boost approaches to tuberculosis vaccine development Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection.The development of a novel Mycobacterium-Escherichia coli shuttle vector system using pMyong2, a linear plasmid from Mycobacterium yongonense DSM 45126T.Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.Protective vaccine efficacy of the complete form of PPE39 protein from Mycobacterium tuberculosis Beijing/K strain in mice.HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells.The O-mannosylation and production of recombinant APA (45/47 KDa) protein from Mycobacterium tuberculosis in Streptomyces lividans is affected by culture conditions in shake flasks.

P2860

Q27024526-16FD6747-775E-44F1-A319-B0C789894DD8 Q27315911-F0A33EEA-A1BD-48CB-9797-91B1BAAA2453 Q27323963-A6D1ED47-640D-4D98-BE53-1EA98C9EC8A0 Q34024201-BE956920-D8B0-43A2-A029-AE06E585B70B Q34566311-7BFD901C-5CA1-4D8D-9FBF-047F5B615294 Q35018095-16A57683-CF34-45D6-B0A9-71A1BEC71BE0 Q35231090-354EA705-23B5-460E-A3DF-69BCA8725ABA Q36417953-FB662C77-01E4-4256-A760-CFDDA1C103F8 Q37124690-EB5D595C-A449-44FC-9386-22B27F473171 Q37505396-FE6C8F55-03AF-4F68-9F9B-24D5B5273997 Q37627859-30256BD3-C50B-4ACA-A568-1BE5A5645ABB Q40064027-00133002-A929-4E7B-BDA8-DDD1FB2573DB Q40147542-1DECFA63-8D5A-4FAA-B8FC-2C8DEDDC66EF Q40674708-8CA05B1E-1124-44F9-AAF9-5D6CDC3063CC

P2860

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.

http://www.wikidata.org/entity/Q31028998

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cellular immune responses to n ...... lowing intranasal vaccination.

@ast

Cellular immune responses to n ...... lowing intranasal vaccination.

@en

type

label

Cellular immune responses to n ...... lowing intranasal vaccination.

@ast

Cellular immune responses to n ...... lowing intranasal vaccination.

@en

prefLabel

Cellular immune responses to n ...... lowing intranasal vaccination.

@ast

Cellular immune responses to n ...... lowing intranasal vaccination.

@en

P1433

Q31028998-DAB7824C-C056-4358-9D1B-0741D27FD6EF

P1476

Q31028998-D68F3783-1148-4C65-9FC7-CE0457CE2B11

P2093

Q31028998-0D69FA66-7342-4899-B433-590AD3834930

Q31028998-2109BAFA-2172-4003-90F1-4AD2CE3D7A71

Q31028998-257E7BBD-31CE-4F31-B730-D6DB27E8F957

Q31028998-4382D26D-1E6A-4536-B29D-EB9ECD8E9D91

Q31028998-8EA17C49-A8EA-429E-A61A-3554C2A67DAB

Q31028998-8EF4E4E3-EC24-496C-AA93-ABA581148557

Q31028998-97537848-DEB7-49E6-A2E6-2F267EB858B7

Q31028998-C488CF26-CD72-4A5D-81E4-98BBEDAE9C3F

Q31028998-DC43C370-ACA4-402F-A76A-246A31324E3D

P2860

Q31028998-00D68E69-F907-426C-A45B-B0BB3C0F8659

Q31028998-09B1C75B-26B0-4EBF-A478-6C793B3452D6

Q31028998-174382BC-E02C-4CAF-ADE6-491E59661921

Q31028998-19F4C681-ECE0-4D7F-BFD6-289B46E32B7F

Q31028998-1A31AA8D-6D8C-473C-AA8B-F13D311BD813

Q31028998-1DF176BB-F08E-4E0D-B50F-AF4F311B3363

Q31028998-1E72B560-FA78-486F-AB2A-E2F672BC5607

Q31028998-20E8F097-3E83-43EA-B197-0ECB0EC70E19

Q31028998-215034CB-5440-47CF-BFDC-045D38CFAE4E

Q31028998-224B3DA2-BD88-48B0-9F3A-9079FEF36902

P304

Q31028998-5068AF6E-752A-4038-A734-2D9FFD1FAB44

P31

Q31028998-6ECC39E1-9FBF-4507-BE4A-9AF438E88F91

P356

Q31028998-41156901-C181-4D8D-B4D4-B3E414604966

P407

Q31028998-43D8977D-8F44-44F1-B764-F6470BF9DF1D

P433

Q31028998-D4EB07CF-603E-42C8-994D-F8CC43237212

P478

Q31028998-71C0DDC7-6834-4F4E-9BD6-B14543BCD2EB

P50

Q31028998-F07FECB4-54CA-4002-A569-B6FFBEE797E8

P577

Q31028998-D281FEA9-D945-4315-A4EA-AD8E3B1ED387

P5875

Q31028998-D72D9F87-B501-4978-97E0-2B17925D18F9

P698

Q31028998-4D1351E8-E1E6-4F69-9278-7EA7783059B0

P921

Q31028998-71EACF02-32A3-4B7D-BA72-3661E61C5B35

P932

Q31028998-B8E71814-93F9-4B46-B572-CB537F3DFF44

P356

JOURNAL.PONE.0022718

P1433

P1476

Cellular immune responses to n ...... lowing intranasal vaccination.

@en

P2093

Bonnie B Plikaytis

http://www.w3.org/2001/XMLSchema#string

James E Posey

http://www.w3.org/2001/XMLSchema#string

Kakali Bandyopadhyay

http://www.w3.org/2001/XMLSchema#string

Kathryn L Kellar

http://www.w3.org/2001/XMLSchema#string

Mani Cheruvu

http://www.w3.org/2001/XMLSchema#string

Rama Rao Amara

http://www.w3.org/2001/XMLSchema#string

Subhadra Nandakumar

http://www.w3.org/2001/XMLSchema#string

Sunita Sharma

http://www.w3.org/2001/XMLSchema#string

Thomas M Shinnick

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis

Future Vaccination Strategies against Tuberculosis: Thinking outside the Box

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity

The population dynamics and control of tuberculosis

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model.

Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern.

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose

P304

e22718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0022718

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51531343

http://www.w3.org/2001/XMLSchema#string

P698

21799939

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

3143185

http://www.w3.org/2001/XMLSchema#string